Advances in Hematology and Oncology: Novel Therapies for Lymphoma


Advances in Hematology and Oncology: Novel Therapies for Lymphoma Banner

Add to Calendar Advances in Hematology and Oncology: Novel Therapies for Lymphoma 10/22/2021 8:00:00 AM 10/22/2021 12:30:00 PM America/New_York For More Details: https://iu.cloud-cme.com/NovelTherapiesforLymphoma Description: The Brown Center for Immunotherapy at Indiana University will host a CME virtual conference entitled Advances in Hematology and Oncology: Immunotherapy and Other Novel Approaches to Lymphoma. Antibodies, cell therapies and gene therapies have the potential to greatly improve the prognosis of patients with life-threatening illnesses. A challenge for interprofessional healthcare clinicians is keeping pace with th... virtual false MM/DD/YYYY


Date & Location
Friday, October 22, 2021, 8:00 AM - 12:30 PM, virtual

Target Audience
Specialties - Biochemical Genetics , Blood Banking - Transfusion Medicine, Cardiovascular Disease , Critical Care Medicine, Hematology, Hematology and Oncology, Hospitalist, Internal Medicine, Internal Medicine-Pediatrics, Medical Genetics, Molecular Genetic Pathology, Oncology, Pathology-Anatomic and Clinical, Pediatric Critical Care Medicine, Pediatric Hematology-Oncology, Pharmacy, Radiation Oncology, Vascular and Interventional Radiology

Overview
The Brown Center for Immunotherapy at Indiana University will host a CME virtual conference entitled Advances in Hematology and Oncology: Immunotherapy and Other Novel Approaches to Lymphoma. Antibodies, cell therapies and gene therapies have the potential to greatly improve the prognosis of patients with life-threatening illnesses. A challenge for interprofessional healthcare clinicians is keeping pace with the rapidly advancing technology and clinical applications. Patients also inquire about options based on reports in the press or on the internet. This CME course will increase participant’s understanding of the biology, expected outcomes, and potential adverse events associated with novel therapies. The goal of this program is to improve the knowledge base and applicable strategies of the team regarding technologic advances, ongoing clinical trials, and FDA approved therapies. The anticipated outcome is empowerment of participants to provide counseling and appropriate referrals.

Objectives
At the conclusion of this activity, participants should be able to:

  1. Describe the general mechanism of action of these novel biologic agents after a review of immunotherapy, cell and gene therapy technology;
  2. Judge whether immunotherapy, cell and gene therapy is an appropriate option to discuss with lymphoma patients based on specific clinical scenarios; and
  3. Better council lymphoma patients who inquire about novel therapies based on explanation of the terminology and clinical applications.

Registration

Registration open now!

The registration is free. Pre-registration is required.


Accreditation
In support of improving patient care, Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Nurses
Indiana University School of Medicine designates this activity for a maximum of 3.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists
Indiana University School of Medicine designates this activity for 3.50 ACPE contact hours. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

Physicians
Indiana University School of Medicine designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected]. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.


Credits
AMA PRA Category 1 Credits™ (3.50 hours), ACPE Contact Hours (3.50 hours), ANCC Contact Hours (3.50 hours), Non-Physician Attendance (3.50 hours)